Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARL.L Regulatory News (ARL)

  • There is currently no data for ARL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Jan 2005 09:33

XKO Group PLC06 January 2005 XKO Group Plc 6 January 2005 XKO Group plc ("the Company") DISCLOSURE OF INTEREST IN SHARES XKO Group plc received notification on 5 January 2005 that Arlington Group plcdisposed of 1 million ordinary shares in the Company at a price of 75.5p.Arlington Group plc now holds 1.5 million ordinary shares in XKO Group plcequating to 5.43% of the Company. This is based on an issued share capital of27,648,314. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jun 200512:14 pmRNSHolding(s) in Company
24th May 20052:07 pmRNSHolding(s) in Company
18th Apr 20057:57 amRNSPut option exercise
18th Apr 20057:00 amRNSDisposal
30th Mar 200510:22 amRNSWarrant Agreement
23rd Feb 20053:39 pmRNSTransaction in Own Shares
26th Jan 200510:56 amRNSCancellation and re-admission
21st Jan 20051:16 pmRNSHolding(s) in Company
14th Jan 20053:32 pmRNSRule 8 - Prestbury Holdings
13th Jan 20052:03 pmRNSScheme of arrangement
6th Jan 20059:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.